Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituxan and IL-2 in Low Grade or Follicular B-Cell Lymphoma
NCT00003356Phase 2Completed
- Sponsor
- University of Rochester
- Start
- Nov 1997
- Primary completion
- May 2002
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of aldesleukin in Mantle cell lymphoma (MCL), Follicular lymphoma (FL), B-cell lymphoma (BCL), sponsored by University of Rochester. Started Nov 1997; status: completed.
02
Drugs
aldesleukin
03
Conditions
Mantle cell lymphoma (MCL)Follicular lymphoma (FL)B-cell lymphoma (BCL)
Beyond the preview
Go deeper on NCT00003356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003356.